Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Juniperus Ashei Pollen is a non-standardized allergenic extract used in the diagnosis and treatment of Mountain Cedar allergy. It belongs to the class of pollen allergenic extracts and is primarily utilized in allergen-specific immunotherapy (AIT).
Name
Juniperus Ashei Pollen
Raw Name
JUNIPERUS ASHEI POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
21
Variant Count
23
Last Verified
February 17, 2026
About Juniperus Ashei Pollen
Juniperus Ashei Pollen is a non-standardized allergenic extract used in the diagnosis and treatment of Mountain Cedar allergy. It belongs to the class of pollen allergenic extracts and is primarily utilized in allergen-specific immunotherapy (AIT).
Detailed information about Juniperus Ashei Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Juniperus Ashei Pollen.
Juniperus Ashei Pollen, commonly known as Mountain Cedar pollen, is a biological substance used primarily in the field of clinical allergy and immunology. It belongs to a class of drugs known as Non-Standardized Pollen Allergenic Extracts [EPC]. These extracts are derived from the pollen of the Juniperus ashei tree, a species native to the Southwestern United States, particularly Texas, Oklahoma, and parts of Northern Mexico. This specific pollen is the primary culprit behind the seasonal allergic rhinitis colloquially known as "Cedar Fever," which affects millions of individuals during the winter months (typically December through March).
In clinical practice, Juniperus Ashei Pollen extract is utilized for two main purposes: the diagnosis of hypersensitivity (allergy) to Mountain Cedar and the treatment of such allergies through allergen-specific immunotherapy (AIT). Immunotherapy involves the repeated administration of the allergen to a patient in gradually increasing doses. The goal is to modify the patient's immune response, moving it away from an allergic (IgE-mediated) reaction and toward a state of immunological tolerance.
According to the FDA-approved labeling and historical regulatory frameworks, these extracts are categorized as non-standardized. This means that unlike "standardized" extracts (such as those for grass or dust mites), which are measured by their biological potency in Bioequivalent Allergy Units (BAU), Juniperus Ashei Pollen is typically measured by its Protein Nitrogen Unit (PNU) content or its weight-to-volume (w/v) ratio. The FDA has regulated allergenic extracts since the early 20th century, with many products being licensed under the Public Health Service Act of 1944.
The mechanism of action for Juniperus Ashei Pollen extract is complex and involves the modulation of the human immune system at multiple cellular levels. When a person with an allergy is exposed to Mountain Cedar pollen naturally, their immune system incorrectly identifies the pollen proteins (such as the major allergen Jun a 1) as harmful invaders. This triggers the production of Immunoglobulin E (IgE) antibodies, which bind to mast cells and basophils. Upon subsequent exposure, the pollen cross-links these IgE antibodies, causing the cells to release inflammatory mediators like histamine, leukotrienes, and prostaglandins, leading to the symptoms of hay fever.
When administered as immunotherapy, Juniperus Ashei Pollen works by reversing this process. Your healthcare provider will typically administer the extract via subcutaneous injection (SCIT). At the molecular level, this repeated exposure induces several key changes:
Traditional pharmacokinetic studies (Absorption, Distribution, Metabolism, and Elimination) are not typically conducted for allergenic extracts like Juniperus Ashei Pollen in the same way they are for small-molecule drugs. Because this is a biological mixture of proteins, its "metabolism" is better described as immunological processing.
Juniperus Ashei Pollen is FDA-approved for the following indications:
Off-label uses are rare, though some specialist clinics may use the extract for sublingual immunotherapy (SLIT) formulations, although the injectable form is the primary FDA-recognized delivery method for non-standardized extracts.
Juniperus Ashei Pollen is available in the following dosage forms:
> Important: Only your healthcare provider can determine if Juniperus Ashei Pollen is right for your specific condition. The administration must be performed under the supervision of a physician prepared to treat systemic anaphylaxis.
Dosage for Juniperus Ashei Pollen is highly individualized and does not follow a "one size fits all" approach. The treatment is divided into two distinct phases: the Build-up Phase and the Maintenance Phase.
During this phase, your healthcare provider will start with an extremely dilute concentration, often as low as 0.05 mL of a 1:100,000 w/v or 1:10,000 w/v dilution. Injections are typically given once or twice a week. The dose is gradually increased with each injection—for example, 0.1 mL, 0.2 mL, 0.3 mL, and so on—until the "maintenance dose" is reached. This phase usually lasts 3 to 6 months.
Once the effective dose is reached (often 0.5 mL of a 1:100 w/v or 1:20 w/v concentration), the frequency of injections is decreased. Most patients receive maintenance injections every 2 to 4 weeks. The goal of this phase is to sustain the immunological tolerance developed during the build-up phase. Maintenance therapy typically continues for 3 to 5 years.
Juniperus Ashei Pollen is generally considered safe and effective for pediatric use in children, typically starting around age 5. Younger children may be treated at the discretion of a specialist if the benefit outweighs the risk and the child is able to cooperate with the injection and observation protocol. The dosing schedule for children is essentially the same as for adults, though the physician may choose a more conservative escalation schedule to monitor for side effects.
No specific dose adjustments are required for patients with kidney disease, as the extract is not cleared through the kidneys in a manner that would lead to toxicity. However, the patient's overall health must be stable.
No dose adjustments are required for patients with liver disease. The metabolism of allergenic proteins is independent of liver function.
While there is no specific age-based dosage adjustment, healthcare providers exercise caution in elderly patients. This is primarily due to the increased likelihood of co-existing cardiovascular disease, which might make the use of emergency epinephrine (if an allergic reaction occurs) more risky.
Juniperus Ashei Pollen extract is administered via subcutaneous injection, usually in the back of the upper arm. It should never be injected intravenously.
If you miss a dose, contact your allergist immediately. The protocol for a missed dose depends on how long it has been since your last injection:
An overdose of Juniperus Ashei Pollen occurs if too much allergen is injected or if the dose is escalated too quickly. This typically results in a systemic allergic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Most patients undergoing immunotherapy with Juniperus Ashei Pollen will experience local reactions. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Juniperus Ashei Pollen and call your doctor or emergency services immediately if you experience any of these symptoms of anaphylaxis:
There are no known long-term negative health effects associated with the proper use of Juniperus Ashei Pollen immunotherapy. In fact, the long-term "side effect" is usually the desired one: a significant reduction in allergy symptoms that can last for years after the treatment is discontinued. There is no evidence that immunotherapy increases the risk of autoimmune diseases or cancer. However, if a patient is repeatedly subjected to systemic reactions, there is a theoretical risk of increased sensitivity, though this is managed by adjusting the treatment protocol.
While Juniperus Ashei Pollen may not always carry a specific "Black Box" on every individual vial label depending on the manufacturer, the FDA requires a General Warning for all allergenic extracts regarding Anaphylaxis.
Summary of Warning: This product can cause severe, life-threatening systemic allergic reactions, including anaphylaxis. It must only be administered by healthcare professionals trained in the management of anaphylaxis and in a facility equipped with emergency supplies (epinephrine, oxygen, IV fluids). Patients with unstable asthma are at a higher risk for fatal reactions. Patients taking beta-blockers may be resistant to the effects of epinephrine used during an emergency.
Report any unusual symptoms to your healthcare provider.
Juniperus Ashei Pollen is a potent biological substance. Safety is paramount, and the therapy requires a high level of patient compliance. You must be able to attend regular appointments and stay for the required observation period. If you are feeling unwell, have a fever, or are experiencing an asthma flare-up, you must inform your doctor before receiving your injection, as these factors increase the risk of a reaction.
No specific individual black box warning is unique to Juniperus Ashei Pollen beyond the class-wide FDA warning for allergenic extracts. This warning emphasizes that Anaphylaxis is a constant risk and that the drug should only be administered in settings where emergency resuscitation is possible. Fatalities have occurred with allergenic extracts when these precautions were not followed.
There are no standard blood tests (like liver or kidney function tests) required for Juniperus Ashei Pollen. However, monitoring includes:
Juniperus Ashei Pollen generally does not cause drowsiness or impairment. However, if you experience a systemic reaction or are given antihistamines/epinephrine to treat a reaction, you should not drive or operate machinery until the symptoms have completely resolved and you are cleared by a medical professional.
Alcohol should be avoided for several hours before and after your injection. Alcohol causes vasodilation (widening of blood vessels), which can increase the rate at which the injected pollen is absorbed into the bloodstream, potentially triggering a systemic reaction.
Immunotherapy is typically discontinued after 3-5 years of successful maintenance. There is no "withdrawal syndrome" associated with stopping Juniperus Ashei Pollen. However, if you stop the treatment prematurely (e.g., after only 6 months), your allergy symptoms are likely to return quickly, as the immune system has not had enough time to develop long-term tolerance.
> Important: Discuss all your medical conditions with your healthcare provider before starting Juniperus Ashei Pollen.
For each major interaction, the primary concern is either the increased risk of a systemic allergic reaction or the decreased effectiveness of emergency medications used to treat such a reaction. Management strategies always involve a thorough review of the patient's medication list before the first dose of immunotherapy.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Juniperus Ashei Pollen must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by a specialist:
Patients allergic to Juniperus Ashei Pollen often show cross-sensitivity to other members of the Cupressaceae family. This includes:
If you are allergic to one of these, you may experience a stronger reaction to the Juniperus Ashei extract than expected.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Juniperus Ashei Pollen.
Juniperus Ashei Pollen is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm. The primary concern during pregnancy is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis). Anaphylaxis in the mother can cause a sudden drop in blood pressure and uterine contraction, leading to fetal hypoxia (oxygen deprivation) or miscarriage.
There is no evidence that Juniperus Ashei Pollen proteins are excreted into human breast milk in significant quantities. Furthermore, even if small amounts were present, they would likely be digested in the infant's stomach. Immunotherapy is generally considered safe for breastfeeding mothers. However, the mother should be monitored for systemic reactions, as the stress of a reaction could theoretically affect milk supply.
Immunotherapy is highly effective in children and has been shown to prevent the development of asthma in children with allergic rhinitis. The approved age range usually begins at 5 years.
In patients over 65, the decision to use Juniperus Ashei Pollen is based on cardiovascular health.
No dosage adjustments are needed for patients with renal impairment. The proteins are processed by the immune system and not primarily excreted by the kidneys.
No dosage adjustments are needed for patients with hepatic impairment. The liver does not play a role in the immunological processing of allergenic extracts.
> Important: Special populations require individualized medical assessment.
Juniperus Ashei Pollen extract works through Allergen-Specific Immunotherapy (AIT). The primary molecular target is the T-lymphocyte. By introducing the allergen via a non-mucosal route (subcutaneous), the extract induces "peripheral tolerance." This involves the expansion of CD4+ CD25+ Foxp3+ regulatory T-cells (Tregs). These Tregs secrete Interleukin-10 (IL-10), which suppresses the Th2 response responsible for IgE production. Simultaneously, B-cells are signaled to switch production from IgE to IgG4. IgG4 acts as a "blocking antibody," preventing the Mountain Cedar allergens from binding to IgE on the surface of mast cells.
The effects of Juniperus Ashei Pollen are not immediate.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous Injection) |
| Protein Binding | N/A (Immunological Processing) |
| Half-life | Hours (Proteins), Years (Immune Memory) |
| Tmax | 30-60 minutes (Systemic absorption) |
| Metabolism | Local Proteolysis |
| Excretion | Cellular Degradation |
Juniperus Ashei Pollen extract is a complex biological mixture. It contains various proteins, glycoproteins, and polysaccharides. The most significant component is the Jun a 1 protein, which is a pectate lyase and the major allergen responsible for most clinical symptoms. The extract is typically standardized by weight/volume (e.g., 1:20 w/v) or by Protein Nitrogen Units (PNU), where 1 mg of protein nitrogen equals 100,000 PNU. It is soluble in water and saline and is usually buffered with phosphates and stabilized with 50% glycerin.
Juniperus Ashei Pollen is classified as a Non-Standardized Pollen Allergenic Extract [EPC]. It belongs to the broader category of Biologics and Immunomodulators. Related medications include other tree pollen extracts (e.g., Oak, Pecan) and standardized extracts like Short Ragweed or Timothy Grass.
Common questions about Juniperus Ashei Pollen
Juniperus Ashei Pollen extract is primarily used for the diagnosis and treatment of Mountain Cedar allergies, commonly known as 'Cedar Fever.' Healthcare providers use it in skin prick tests to confirm if a patient is allergic to this specific tree pollen. In treatment, it is used for allergen-specific immunotherapy, which involves giving the patient gradually increasing doses of the pollen to build up immunity. This process helps reduce symptoms like sneezing, itchy eyes, and nasal congestion during the winter cedar season. It is intended for patients who do not get enough relief from standard allergy medications.
The most common side effects are local reactions at the site of the injection, such as redness, itching, and swelling. These reactions are typically mild and go away within a few hours or a day. Some patients may also experience a temporary increase in their usual allergy symptoms, like sneezing or a runny nose, shortly after the treatment. Occasionally, patients report feeling slightly tired after their appointment. While these are common, any reaction larger than a few centimeters should be reported to your doctor for dosage adjustment.
It is strongly recommended that you avoid drinking alcohol for several hours before and after receiving a Juniperus Ashei Pollen injection. Alcohol causes your blood vessels to dilate (widen), which can significantly speed up the absorption of the pollen extract into your bloodstream. This rapid absorption increases the risk of a systemic allergic reaction or anaphylaxis. To ensure your safety, it is best to wait until the following day to consume alcohol. Always discuss your lifestyle habits with your allergist during your consultation.
Juniperus Ashei Pollen is generally not started during pregnancy because of the risk of a severe allergic reaction, which could harm the developing fetus by reducing oxygen levels. However, if a woman is already on a stable maintenance dose and becomes pregnant, many doctors allow the treatment to continue since the risk of a reaction is much lower at that stage. The decision is made on a case-by-case basis by weighing the benefits of allergy control against the potential risks. You must inform your allergist immediately if you become pregnant or are planning to conceive. Most specialists prioritize the mother's safety and the stability of her immune system during this time.
Immunotherapy with Juniperus Ashei Pollen is a long-term commitment and does not provide immediate relief. Most patients begin to notice a significant improvement in their 'Cedar Fever' symptoms after 3 to 6 months of treatment, usually once they have reached their maintenance dose. The full benefits are typically seen after the first full cedar season on maintenance therapy. For the best and most lasting results, the treatment usually needs to be continued for 3 to 5 years. This duration allows the immune system to fully 'relearn' its response to the pollen.
Yes, you can stop taking the injections at any time without experiencing physical withdrawal symptoms, as it is not an addictive substance. However, if you stop before completing the recommended 3-to-5-year course, your allergy symptoms are likely to return during the next cedar season. The progress you made in building up your immunity may be lost if the treatment is discontinued too early. If you need to stop due to financial, travel, or health reasons, discuss a plan with your doctor. They can advise you on how long your current level of protection might last.
If you miss a scheduled injection, you should contact your allergist's office as soon as possible to reschedule. Do not simply wait for your next regular appointment, as the timing of these injections is crucial for safety. If you miss only a week, your doctor may be able to give you your regular dose. However, if several weeks have passed, your doctor will likely need to reduce your dose and gradually build it back up to prevent a reaction. Never attempt to 'double up' on a dose to make up for a missed one.
There is no clinical evidence to suggest that Juniperus Ashei Pollen extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are sometimes used for severe allergies and can cause weight changes, allergenic extracts are biological proteins that work specifically on the immune system. They do not affect your metabolism, appetite, or fat storage. If you notice weight changes while on immunotherapy, it is likely due to other factors or medications. You should discuss any concerns about weight with your primary care physician.
Juniperus Ashei Pollen can be taken alongside most common medications, but there are some critical exceptions. You must tell your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make the treatment more dangerous or interfere with emergency care. Most standard allergy medications, like antihistamines and nasal sprays, are fine to use and are often encouraged to manage symptoms during the build-up phase. However, do not take a new antihistamine right before your injection without telling your doctor, as it might mask early signs of a reaction. Always provide a full list of your supplements and prescriptions to your allergist.
Allergenic extracts like Juniperus Ashei Pollen are biological products rather than simple chemical drugs, so the term 'generic' does not apply in the traditional sense. However, multiple manufacturers produce Mountain Cedar pollen extracts, and they are generally considered interchangeable by allergists, provided the concentration (PNU or w/v) is carefully matched. Your insurance may have a preference for one manufacturer over another. When your doctor starts a new vial from a different manufacturer, they may slightly reduce your dose for one visit to ensure you tolerate the new preparation safely.